A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 28-DAY STUDY OF D

D 的多中心、双盲、随机、安慰剂对照、为期 28 天的研究

• 批准号: 7375973
• 负责人: Carlos Milla
• 金额: $ 1.72万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375973
• 关键词: MULTI; CENTER; DOUBLE; BLIND; RANDOMIZED

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objectives of this study are to evaluate the safety and tolerability of two dose levels of INS37217 Inhalation Solution compared to placebo administered three times daily over 28 days in patients with CF lung disease and to gain preliminary evidence of efficacy.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。本研究的目的是在CF肺病患者中评价两种剂量水平的INS 37217吸入溶液与安慰剂相比每日三次给药持续28天的安全性和耐受性，并获得疗效的初步证据。